Cargando…
Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977396/ https://www.ncbi.nlm.nih.gov/pubmed/31758540 http://dx.doi.org/10.1002/cpt.1689 |
| _version_ | 1783490501237800960 |
|---|---|
| author | Arlett, Peter Straus, Sabine Rasi, Guido |
| author_facet | Arlett, Peter Straus, Sabine Rasi, Guido |
| author_sort | Arlett, Peter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6977396 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69773962020-01-28 Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics Arlett, Peter Straus, Sabine Rasi, Guido Clin Pharmacol Ther Perspectives John Wiley and Sons Inc. 2019-11-22 2020-01 /pmc/articles/PMC6977396/ /pubmed/31758540 http://dx.doi.org/10.1002/cpt.1689 Text en © 2019 The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/3.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Perspectives Arlett, Peter Straus, Sabine Rasi, Guido Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics |
| title | Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics |
| title_full | Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics |
| title_fullStr | Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics |
| title_full_unstemmed | Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics |
| title_short | Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics |
| title_sort | pharmacovigilance 2030: invited commentary for the january 2020 “futures” edition of clinical pharmacology and therapeutics |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977396/ https://www.ncbi.nlm.nih.gov/pubmed/31758540 http://dx.doi.org/10.1002/cpt.1689 |
| work_keys_str_mv | AT arlettpeter pharmacovigilance2030invitedcommentaryforthejanuary2020futureseditionofclinicalpharmacologyandtherapeutics AT straussabine pharmacovigilance2030invitedcommentaryforthejanuary2020futureseditionofclinicalpharmacologyandtherapeutics AT rasiguido pharmacovigilance2030invitedcommentaryforthejanuary2020futureseditionofclinicalpharmacologyandtherapeutics |